Development and analysis of furazolidone-resistant Escherichia coli mutants.

about

Comparative analysis of antimicrobial resistance in enterotoxigenic Escherichia coli isolates from two paediatric cohort studies in Lima, Peru.Alanine Enhances Aminoglycosides-Induced ROS Production as Revealed by Proteomic Analysis.

P2860

Q36117423-043763A3-001E-43EF-81F4-F83836F8E038 Q49395906-27CB4848-E08A-4A1C-8631-3438CE81F9AC

P2860

Development and analysis of furazolidone-resistant Escherichia coli mutants.

Item

http://www.wikidata.org/entity/Q39220947

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Development and analysis of furazolidone-resistant Escherichia coli mutants.

@en

Development and analysis of furazolidone-resistant Escherichia coli mutants.

@nl

type

Item

label

Development and analysis of furazolidone-resistant Escherichia coli mutants.

@en

Development and analysis of furazolidone-resistant Escherichia coli mutants.

@nl

prefLabel

Development and analysis of furazolidone-resistant Escherichia coli mutants.

@en

Development and analysis of furazolidone-resistant Escherichia coli mutants.

@nl

P1476

Development and analysis of furazolidone-resistant Escherichia coli mutants

@en

P2093

Alba Torrents de la Peña

http://www.w3.org/2001/XMLSchema#string

Maria J Pons

http://www.w3.org/2001/XMLSchema#string

P2860

Development of Escherichia coli rifaximin-resistant mutants: frequency of selection and stability

Expression, crystallization and preliminary X-ray crystallographic studies of the outer membrane protein OmpW from Escherichia coli.

Treatment of Giardiasis.

Proteomic analysis of nalidixic acid resistance in Escherichia coli: identification and functional characterization of OM proteins.

Comparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strain

Antimicrobial resistance in developing countries

Furazolidone-based triple and quadruple eradication therapy for Helicobacter pylori infection

Estimating child mortality due to diarrhoea in developing countries

Current treatment options for Dientamoeba fragilis infections.

Analysis of quinolone-resistance in commensal and diarrheagenic Escherichia coli isolates from infants in Lima, Peru

P304

676-681

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/APM.12401

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Sandra Martínez-Puchol

P577

2015-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26011027

http://www.w3.org/2001/XMLSchema#string

P921

Escherichia coli

Development and analysis of furazolidone-resistant Escherichia coli mutants.

about

P2860

P2860

Development and analysis of furazolidone-resistant Escherichia coli mutants.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921